Besides, it is well described role as a lipid chaperone and adiposity biomarker, FABP-4 is associated with features of the metabolic syndrome, insulin resistance, atherosclerosis, and low-grade inflammation and has been proposed as a biomarker for cardiovascular disease and heart failure [16]. Here, FABP4 is linked to cardiovascular disorder.